Payment overview · 2025
General Payments
$350.07
6 reported records · 4 companies
Healthcare provider profile · identity verified
Amish V. Patel, MD
Allopathic & Osteopathic Physicians|Family Medicine|Geriatric Medicine · RALEIGH, NC · NPI 1932384955
Verified facts
What the public records show
CMS Open Payments records show Amish V. Patel, MD received $350.07 in general payments during 2025 across 6 reported records.
Abbott Laboratories accounted for 46.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 117 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $163.48 | 46.7% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $157.24 | 44.9% | 3 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $14.72 | 4.2% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $14.63 | 4.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $335.44 | 5 |
| Education | $14.63 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AMPLATZER AMULET Normalized: amplatzer amulet |
Device | Abbott Laboratories | $163.48 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $157.24 | 3 | 2025 |
Source payment records
|
|||||
| KISUNLA Normalized: kisunla |
Drug | Lilly USA, LLC | $14.72 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $14.63 | 1 | 2025 |
Source payment records
|
|||||
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $11.02 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
117 | 16 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
31 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 734 | 130 |
| Atorvastatin Calcium | Atorvastatin Calcium | 646 | 135 |
| Eliquis | Apixaban | 522 | 85 |
| Metoprolol Succinate | Metoprolol Succinate | 463 | 92 |
| Donepezil Hcl | Donepezil Hcl | 462 | 71 |
| Amlodipine Besylate | Amlodipine Besylate | 407 | 93 |
| Furosemide | Furosemide | 373 | 87 |
| Gabapentin | Gabapentin | 361 | 69 |
| Potassium Chloride | Potassium Chloride | 336 | 64 |
| Pantoprazole Sodium | Pantoprazole Sodium | 302 | 67 |
| Sertraline Hcl | Sertraline Hcl | 295 | 55 |
| Lisinopril | Lisinopril | 282 | 61 |
| Losartan Potassium | Losartan Potassium | 282 | 59 |
| Mirtazapine | Mirtazapine | 279 | 58 |
| Memantine Hcl | Memantine Hcl | 249 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 244 | 44 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 225 | 47 |
| Metoprolol Tartrate | Metoprolol Tartrate | 210 | 40 |
| Famotidine | Famotidine | 195 | 41 |
| Trazodone Hcl | Trazodone Hcl | 189 | 46 |
| Fluticasone Propionate | Fluticasone Propionate | 173 | 70 |
| Omeprazole | Omeprazole | 172 | 54 |
| Tamsulosin Hcl | Tamsulosin Hcl | 172 | 40 |
| Duloxetine Hcl | Duloxetine Hcl | 171 | 26 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 155 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 155 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 155 | 27 |
| Simvastatin | Simvastatin | 149 | 31 |
| Metformin Hcl | Metformin Hcl | 138 | 30 |
| Xarelto | Rivaroxaban | 129 | 19 |
| Meloxicam | Meloxicam | 126 | 30 |
| Alendronate Sodium | Alendronate Sodium | 122 | 20 |
| Ezetimibe | Ezetimibe | 120 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 119 | 22 |
| Jardiance | Empagliflozin | 117 | 16 |
| Carvedilol | Carvedilol | 113 | 29 |
| Latanoprost | Latanoprost | 112 | 27 |
| Finasteride | Finasteride | 111 | 25 |
| Cephalexin | Cephalexin | 109 | 54 |
| Buspirone Hcl | Buspirone Hcl | 106 | 19 |
| Hydrochlorothiazide | Hydrochlorothiazide | 105 | 28 |
| Lorazepam | Lorazepam | 99 | 34 |
| Citalopram Hbr | Citalopram Hydrobromide | 96 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 94 | 15 |
| Tramadol Hcl | Tramadol Hcl | 94 | 34 |
| Amiodarone Hcl | Amiodarone Hcl | 93 | 17 |
| Olanzapine | Olanzapine | 92 | 12 |
| Myrbetriq | Mirabegron | 88 | 13 |
| Bupropion Xl | Bupropion Hcl | 86 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 85 | 39 |
| Valsartan | Valsartan | 81 | 14 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 80 | 55 |
| Pravastatin Sodium | Pravastatin Sodium | 79 | 16 |
| Bumetanide | Bumetanide | 78 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 74 | 13 |
| Montelukast Sodium | Montelukast Sodium | 72 | 17 |
| Spironolactone | Spironolactone | 71 | 21 |
| Baclofen | Baclofen | 69 | suppressed |
| Allopurinol | Allopurinol | 67 | 20 |
| Prednisone | Prednisone | 67 | 28 |
| Midodrine Hcl | Midodrine Hcl | 65 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 65 | suppressed |
| Alprazolam | Alprazolam | 63 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 63 | suppressed |
| Methotrexate | Methotrexate Sodium | 63 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 62 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 61 | 48 |
| Levetiracetam | Levetiracetam | 59 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 57 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 57 | 40 |
| Pregabalin | Pregabalin | 56 | suppressed |
| Torsemide | Torsemide | 56 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 53 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 53 | 22 |
| Risperidone | Risperidone | 51 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 50 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 47 | suppressed |
| Primidone | Primidone | 43 | suppressed |
| Nystatin | Nystatin | 42 | 20 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 42 | suppressed |
| Ondansetron Odt | Ondansetron | 41 | 25 |
| Verapamil Er | Verapamil Hcl | 41 | suppressed |
| Atenolol | Atenolol | 40 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 40 | 22 |
| Clonazepam | Clonazepam | 39 | 11 |
| Ketoconazole | Ketoconazole | 39 | 19 |
| Albuterol Sulfate | Albuterol Sulfate | 38 | suppressed |
| Topiramate | Topiramate | 38 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 38 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 37 | 13 |
| Memantine Hcl Er | Memantine Hcl | 37 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 36 | suppressed |
| Rivastigmine | Rivastigmine | 36 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 35 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 35 | suppressed |
| Budesonide | Budesonide | 34 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Amoxicillin | Amoxicillin | 33 | 19 |
| Armour Thyroid | Thyroid,pork | 33 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 33 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 32 | 26 |
| Doxazosin Mesylate | Doxazosin Mesylate | 32 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 32 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | suppressed |
| Trulicity | Dulaglutide | 31 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 30 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 30 | 14 |
| Silodosin | Silodosin | 30 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 29 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 29 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 27 | 18 |
| Liothyronine Sodium | Liothyronine Sodium | 26 | suppressed |
| Azithromycin | Azithromycin | 25 | 20 |
| Brilinta | Ticagrelor | 25 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 25 | suppressed |
| Glimepiride | Glimepiride | 25 | suppressed |
| Nyamyc | Nystatin | 25 | 17 |
| Paroxetine Hcl | Paroxetine Hcl | 25 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 25 | suppressed |
| Timolol Maleate | Timolol Maleate | 25 | suppressed |
| Irbesartan | Irbesartan | 24 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 24 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 24 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 24 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 24 | suppressed |
| Celecoxib | Celecoxib | 23 | 11 |
| Diltiazem Hcl | Diltiazem Hcl | 23 | suppressed |
| Estradiol | Estradiol | 23 | 13 |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 23 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 23 | 18 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 17 |
| Arformoterol Tartrate | Arformoterol Tartrate | 22 | suppressed |
| Cefdinir | Cefdinir | 22 | 14 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 22 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 22 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Nitroglycerin | Nitroglycerin | 22 | 16 |
| Clonidine Hcl | Clonidine Hcl | 21 | 11 |
| Glipizide Er | Glipizide | 21 | suppressed |
| Ramipril | Ramipril | 21 | suppressed |
| Synthroid | Levothyroxine Sodium | 21 | suppressed |
| Eplerenone | Eplerenone | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Nystop | Nystatin | 20 | 13 |
| Ranolazine Er | Ranolazine | 20 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 19 | suppressed |
| Hydrocortisone | Hydrocortisone | 19 | 11 |
| Januvia | Sitagliptin Phosphate | 19 | suppressed |
| Telmisartan | Telmisartan | 19 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 18 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 18 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 18 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 16 |
| Cefuroxime | Cefuroxime Axetil | 17 | 11 |
| Ibandronate Sodium | Ibandronate Sodium | 17 | suppressed |
| Letrozole | Letrozole | 17 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 17 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 17 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Anastrozole | Anastrozole | 16 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Glipizide | Glipizide | 16 | suppressed |
| Lumigan | Bimatoprost | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 16 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 15 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Gemtesa | Vibegron | 15 | suppressed |
| Lamotrigine | Lamotrigine | 15 | suppressed |
| Metolazone | Metolazone | 15 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Temazepam | Temazepam | 15 | suppressed |
| Tradjenta | Linagliptin | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 14 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Cyclosporine | Cyclosporine | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Mirabegron Er | Mirabegron | 13 | suppressed |
| Clonidine | Clonidine | 12 | suppressed |
| Dutasteride-Tamsulosin | Dutasteride/Tamsulosin Hcl | 12 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 12 | suppressed |
| Invokamet Xr | Canagliflozin/Metformin Hcl | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 12 | 11 |
| Probenecid | Probenecid | 12 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 12 | suppressed |
| Rhopressa | Netarsudil Mesylate | 12 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Trandolapril | Trandolapril | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 11 | suppressed |
| Droxidopa | Droxidopa | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 11 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $350.07 · 6 records | Abbott Laboratories | AMPLATZER AMULET, EVENITY, KISUNLA, PROLIA, REXULTI | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error